2014 Cannabinoids Clinical Trials Epilepsy 
Cannabis Law Report
JANUARY 10, 2022
Minor Cannabinoids Market Size, Share & Trends Analysis Report by Product (CBG, CBC, CBN, THCV, CBGA), by Application (Pain Management, Neurological Disorders), and Segment Forecasts, 2021-2028” report has been added to ResearchAndMarkets.com’s offering. minor cannabinoids market size is expected to reach USD 26.2
Cannabis Law Report
SEPTEMBER 24, 2019
T he EU has approved for the first time the use of a medicinal cannabis product aimed at patients with two rare, but severe, forms of childhood epilepsy. The medication, developed by GW Pharmaceuticals, will be used in combination with another epilepsy medication called clobazam. What about other medical cannabis products? PDF Version.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
CannaMD
AUGUST 8, 2020
In honor of National CBD Day, CannaMD wants to clear up some cannabinoid confusion once and for all. However, many of these products contain a number of other cannabinoids as well. To understand cannabinoids, we need to take a closer look at the endocannabinoid system. In 1970, the U.S.
Canna Care Docs
DECEMBER 16, 2020
Among the 100-plus chemicals called cannabinoids in the cannabis plant, the two that are best known for their medicinal benefits are tetrahydrocannabinol (THC) and cannabidiol (CBD). What is medical marijuana? Medical marijuana is the use of the marijuana plant or its chemicals to treat various diseases or conditions. Chronic pain.
Healer
DECEMBER 17, 2021
Drug interactions reported in the scientific literature most often occur at very high doses used in clinical trials of epilepsy and other conditions. Since cannabinoids, including CBD, share metabolic pathways with other drugs, and have similar mechanisms of action with other drugs, the potential for interaction exists.
Healer
DECEMBER 17, 2021
Drug interactions reported in the scientific literature most often occur at very high doses used in clinical trials of epilepsy and other conditions.[1]. Since cannabinoids, including CBD, share metabolic pathways with other drugs, and have similar mechanisms of action with other drugs, the potential for interaction exists.
Cannabis Law Report
SEPTEMBER 1, 2019
Both US states legalised recreational cannabis in 2014, and had seen spectacular economic results. I actually produce more natural cannabinoids than the average person – that’s helped me recover from seven strokes,” says Elisabetta Faenza, now CEO of Australian medicinal cannabis company LeafCann. But not everyone agrees. “I
Expert insights. Personalized for you.
52 
Let's personalize your content